Add to Calendar 8/26/2020 8:00:00 AM 8/27/2020 5:00:00 PM 2020 State of Possible Conference

Special thanks to our Platinum Sponsor Morgan Stanley

Registered attendees will receive an email with the subject line “Welcome to the State of Possible Conference 2020 - Event Access Link” from registrations@bizzabo.com.


The State of Possible Conference, MassBio's Annual Meeting, will now be hosted virtually on August 26-27, 2020. Featuring interactive networking and a groundbreaking viewer experience, this event will not be your average webinar.  

We will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks®, inspiring and engaging content in the style of a TED Talk.

"It's the Woodstock of Life Sciences, with all-star performers playing their greatest hits all on one stage.” – 2019 State of Possible Conference attendee
 
If you haven’t attended our State of Possible Conference before, it is the premier east coast life sciences conference. We have some of the brightest names in biotech talking about the issues impacting our industry, covering topics from the realities of precision medicine to advancing new drug targets faster.

To inquire about sponsorship opportunities, contact Laura Rudberg.

2020 State of Possible Conference Refund Policy

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Online Conference, Link will be sent in advance of the event.
Vice President & Head of Open Innovation Center, North America-East, Bayer
Imran leads Bayer’s Open Innovation Center for the East Coast, and is responsible for early access to technology and co-creation of new companies. Intrapreneur driving external innovation with entrepreneurs. Drives several mentoring & partnering programs he created at Bayer. Imran is an outcomes driven biopharmaceutical leader, recognized for delivering innovation and being creative, dynamic, and cross functionally capable. Recipient of Boehringer Ingelheim's President Award. Extensive experience covering business development, alliance management, partnering and licensing activities in diagnostics, personalized medicine, therapeutics, and technology platforms with proven track record from Boehringer Ingelheim, Massbio, Genzyme Genetics, Millennium Pharmaceuticals. Possess strong business acumen, critical thinking, negotiations and sophisticated quantitative tools to illuminate business and technology opportunities, structure and negotiate deals, analyze intellectual property and understand financial exposure for drug development programs, technology platforms and new diagnostic services. Proven in negotiation and execution of complex agreements with biopharmaceutical, academic, and government entities enhancing R&D performance, acquiring strategic assets and accelerating product and service launches, covering purchases, collaborations, clinical trials, platform technologies and others. Demonstrable track record at Boehringer Ingelheim, Genzyme Genetics, Millennium Pharmaceuticals, MassBio, Dana Farber Cancer Center and Mayo Clinic. Founded BI Grass Roots Innovation programs – BI Office Hours, BI Academy, and BI Innovation Prize. Additionally, founded Massbio’s Pharma Days and MassConnect, a start-up mentoring service. Additionally, founded PharmaDays, a MassBio partnering service connecting major pharmaceutical companies with biotechnology and the academic community for one-on-one partnering.

Brought to you by